UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies

Strahlentherapie und Onkologie, 2022-06, Vol.198 (6), p.547-557

2022

Link zum Volltext

Verfügbarkeit prüfen

Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome–negative acute lymphoblastic leukemia

Annals of hematology, 2024-02, Vol.103 (2), p.489-498

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Annals of hematology, 2018-02, Vol.97 (2), p.335-342

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

Annals of hematology, 2023-10, Vol.102 (10), p.2903-2908

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac MRI: a Promising Diagnostic Tool to Detect Cancer Therapeutics–Related Cardiac Dysfunction

Current cardiovascular imaging reports, 2019-05, Vol.12 (5), p.1-17, Article 18

2019

Link zum Volltext

Verfügbarkeit prüfen

Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia

Annals of hematology, 2016-05, Vol.95 (6), p.1023-1025

2016

Link zum Volltext

Verfügbarkeit prüfen

The DAC system and associations with acute leukemias and myelodysplastic syndromes

Investigational new drugs, 2010-12, Vol.28 (Suppl 1), p.36-49

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes

Annals of hematology, 2012-08, Vol.91 (8), p.1221-1233

2012

Link zum Volltext

Verfügbarkeit prüfen

Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34+ cell expansion and maturation

International journal of hematology, 2001-01, Vol.73 (1), p.71-77

2001

Link zum Volltext

Verfügbarkeit prüfen

Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia

Annals of hematology, 2014-02, Vol.93 (2), p.193-202

2014

Link zum Volltext

Verfügbarkeit prüfen

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

Annals of hematology, 2005-11, Vol.84 (11), p.748-754

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLink (Online service)
(15)
Ingenta.com
(13)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(12)
MEDLINE
(10)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)

Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome–negative acute lymphoblastic leukemia

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

Cardiac MRI: a Promising Diagnostic Tool to Detect Cancer Therapeutics–Related Cardiac Dysfunction

Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia

The DAC system and associations with acute leukemias and myelodysplastic syndromes

Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial

Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes

Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34+ cell expansion and maturation

Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

Aktive Filter

Suchergebnisse filtern